Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Mar Drugs ; 17(3)2019 Mar 05.
Article in English | MEDLINE | ID: mdl-30841522

ABSTRACT

Fucoxanthin is a carotenoid with many pharmaceutical properties that is found in brown seaweed. However, the effects of fucoxanthin on corneal innervation and intense eye pain have not been extensively examined. To clarify the protective roles and underlying mechanisms of fucoxanthin on ocular lesions, we investigated the beneficial effects and mechanisms by which fucoxanthin ameliorates ultraviolet B (UVB)-induced corneal denervation and trigeminal pain. Treatment with fucoxanthin enhanced the expression of nuclear factor erythroid 2-related factor 2 in the cornea. Inhibition of typical denervation and epithelial exfoliation in the cornea were observed in rats treated with fucoxanthin following UVB-induced nerve disorders. Moreover, the active phosphorylated form of p38 MAP kinase (pp38) and the number of glial fibrillary acidic protein (GFAP)-positive neural cells were significantly reduced. Decreased expression of neuron-selective transient receptor potential vanilloid type 1 (TRPV1) in the trigeminal ganglia neurons was also demonstrated in rats treated with fucoxanthin after UVB-induced keratitis. Symptoms of inflammatory pain, including difficulty in opening the eyes and eye wipe behaviour, were also reduced in fucoxanthin-treated groups. Pre-treatment with fucoxanthin may protect the eyes from denervation and inhibit trigeminal pain in UVB-induced photokeratitis models.


Subject(s)
Eye Pain/drug therapy , Keratitis/drug therapy , Protective Agents/pharmacology , Seaweed/chemistry , Xanthophylls/pharmacology , Administration, Oral , Animals , Cornea/drug effects , Cornea/innervation , Cornea/radiation effects , Denervation , Disease Models, Animal , Eye Pain/etiology , Humans , Keratitis/etiology , Male , Neurons/drug effects , Neurons/metabolism , Protective Agents/therapeutic use , Rats , Rats, Sprague-Dawley , TRPV Cation Channels/metabolism , Trigeminal Ganglion/cytology , Trigeminal Ganglion/drug effects , Trigeminal Ganglion/metabolism , Ultraviolet Rays/adverse effects , Xanthophylls/therapeutic use
2.
PLoS One ; 11(3): e0151495, 2016.
Article in English | MEDLINE | ID: mdl-26986479

ABSTRACT

Forty-two cytopathic effect (CPE)-positive isolates were collected from 2008 to 2012. All isolates could not be identified for known viral pathogens by routine diagnostic assays. They were pooled into 8 groups of 5-6 isolates to reduce the sequencing cost. Next-generation sequencing (NGS) was conducted for each group of mixed samples, and the proposed data analysis pipeline was used to identify viral pathogens in these mixed samples. Polymerase chain reaction (PCR) or enzyme-linked immunosorbent assay (ELISA) was individually conducted for each of these 42 isolates depending on the predicted viral types in each group. Two isolates remained unknown after these tests. Moreover, iteration mapping was implemented for each of these 2 isolates, and predicted human parechovirus (HPeV) in both. In summary, our NGS pipeline detected the following viruses among the 42 isolates: 29 human rhinoviruses (HRVs), 10 HPeVs, 1 human adenovirus (HAdV), 1 echovirus and 1 rotavirus. We then focused on the 10 identified Taiwanese HPeVs because of their reported clinical significance over HRVs. Their genomes were assembled and their genetic diversity was explored. One novel 6-bp deletion was found in one HPeV-1 virus. In terms of nucleotide heterogeneity, 64 genetic variants were detected from these HPeVs using the mapped NGS reads. Most importantly, a recombination event was found between our HPeV-3 and a known HPeV-4 strain in the database. Similar event was detected in the other HPeV-3 strains in the same clade of the phylogenetic tree. These findings demonstrated that the proposed NGS data analysis pipeline identified unknown viruses from the mixed clinical samples, revealed their genetic identity and variants, and characterized their genetic features in terms of viral evolution.


Subject(s)
Genetic Variation , High-Throughput Nucleotide Sequencing/methods , Virus Diseases/virology , Viruses/genetics , Amino Acid Sequence , Animals , Cell Line , Cell Line, Tumor , Dogs , Enzyme-Linked Immunosorbent Assay/methods , Genome, Viral/genetics , Humans , Madin Darby Canine Kidney Cells , Phylogeny , Polymerase Chain Reaction/methods , Recombination, Genetic , Reproducibility of Results , Viruses/classification , Viruses/isolation & purification
3.
Mar Drugs ; 14(1): 13, 2016 Jan 07.
Article in English | MEDLINE | ID: mdl-26751458

ABSTRACT

Ultraviolet B (UVB) irradiation is the most common cause of radiation damage to the eyeball and is a risk factor for human corneal damage. We determined the protective effect of fucoxanthin, which is a carotenoid found in common edible seaweed, on ocular tissues against oxidative UVB-induced corneal injury. The experimental rats were intravenously injected with fucoxanthin at doses of 0.5, 5 mg/kg body weight/day or with a vehicle before UVB irradiation. Lissamine green for corneal surface staining showed that UVB irradiation caused serious damage on the corneal surface, including severe epithelial exfoliation and deteriorated epithelial smoothness. Histopathological lesion examination revealed that levels of proinflammatory cytokines, including tumor necrosis factor-α (TNF-α) and vascular endothelial growth factor (VEGF), significantly increased. However, pretreatment with fucoxanthin inhibited UVB radiation-induced corneal disorders including evident preservation of corneal surface smoothness, downregulation of proinflammatory cytokine expression, and decrease of infiltrated polymorphonuclear leukocytes from UVB-induced damage. Moreover, significant preservation of the epithelial integrity and inhibition of stromal swelling were also observed after UVB irradiation in fucoxanthin-treated groups. Pretreatment with fucoxanthin may protect against UVB radiation-induced corneal disorders by inhibiting expression of proinflammatory factors, TNF-α, and VEGF and by blocking polymorphonuclear leukocyte infiltration.


Subject(s)
Antioxidants/pharmacology , Cornea/radiation effects , Corneal Diseases/prevention & control , Xanthophylls/pharmacology , Animals , Cornea/metabolism , Disease Models, Animal , Male , Rats , Rats, Sprague-Dawley , Seawater , Seaweed , Tumor Necrosis Factor-alpha/metabolism , Ultraviolet Rays , Vascular Endothelial Growth Factor A/metabolism , Xanthophylls/administration & dosage , Xanthophylls/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL